WaPo reports that the Avian flu is not particularly interesting to pharmaceutical companies, although Chiron and Aventis Pasteur are working on vaccination research. WHO has described this as the next pandemic-in-waiting, and has scheduled a meeting 11/11 to urge other pharmaceutical companies to get involved at all in research.
Labels: avian flu, H5N1, pharmaceutical industry, potential pandemics, WHO
